Risk factors for anaplasmosis in dairy cows during the peripartum

Anaplasma marginale is endemic in tropical and subtropical areas around the world. Some studies have suggested that cows during peripartum may present a transient immunosuppression state and development of clinical signs of anaplasmosis. The aim of this study was to investigate the relationship between some risk factors and the seroprevalence of A. marginale in dairy cows during peripartum in Rio de Janeiro, Brazil. The risk factors analyzed in association with the prevalence of antibodies against A. marginale in dairy cows were calving season, reproductive experience, breed standard, tick infestations, stocking density, and milk yield. The antibodies against A. marginale were tested in indirect enzyme-linked immunosorbent assays. A primary screening using a 2 × k contingency table of the exposed variables with the outcomes was performed. All variables for which p?<?0.20 were included in a fixed effects log regression. The risk factors investigated to anaplasmosis were calving (OR 2.61, IC 1.08–7.63), breed standard (OR 3.83, IC 0.08–0.28), reproductive experience (OR 33.7, IC 2.14–5.16), milk yield (OR 3.9, IC 2.24–7.03), Rhipicephalus microplus infestations (OR 10.3, IC 0.05–0.17), and stocking density (OR 22.3, IC 0.05–0.17). Low titers of antibodies against A. marginale during peripartum had been characterized as a period previous to development of clinical anaplasmosis. Thus, studies on anaplasmosis should consider each farm as an epidemiological unit, where environmental and immunological factors may influence the endemic status of the pathogen.     

Estimation of economic loss associated with anaplasmosis in California beef cattle

On the basis of questionnaire surveys and personal interviews with veterinarians, ranchers, and livestock farm advisors, the seriousness of anaplasmosis in California was determined. In 1976, the economic loss due to anaplasmosis in the study sample of beef cattle was $2,203,150. When inferences were made from the sample population to include the whole population of beef cattle, this loss was estimated to be $5,244,319. These values were in contrast to a farm advisors' estimate of $11 million loss due to anaplasmosis, which was included in a total estimated loss of $300 million due to all livestock diseases of economic importance in California. It appeared that anaplasmosis, although having a substantial economic impact in California, is not as economically devastating as it was once thought to be. It was concluded that private programs currently in use (vaccination and treatment) are sufficient to control anaplasmosis.     

Bovine anaplasmosis: susceptibility of seronegative cows from an infected herd to experimental infection with Anaplasma marginale

Adult cows from an Anaplasma marginale-infected herd that were negative to the A marginale rapid card agglutination (RCA) and complement fixation (CF) tests for 1 to 4 years developed acute anaplasmosis after inoculation with 0.5 ml of blood from an A marginale carrier cow. The test cattle were as susceptible as the control cattle of similar ages. Also, 2 cows that had seroconverted from RCA/CF-positive to RCA/CF-negative status naturally were fully susceptible to anaplasmosis when they were experimentally infected. Results of the study indicated that indigenous seronegative cattle in anaplasmosis-enzootic regions probably do not have acquired or natural immunity to A marginale infection.     

Outbreak of anaplasmosis associated with novel genetic variants of Anaplasma marginale in a dairy cattle

During early lactation, dairy cows may present a transient immunosuppressive state and develop anaplasmosis caused by Anaplasma marginale. In this study, clinical anaplasmosis in dairy cattle in the Thrace region of Turkey was investigated with respect to within-herd prevalence, vertical transmission, and genetic diversity. In March and September 2015, thirty lactating cows showed primary clinical signs of anaplasmosis, including fever, anaemia, decreased milk yield, anorexia, and laboured breathing. Symptoms disappeared in most cows after administration of long-acting oxytetracycline, but nine of them (30%) died. Following diagnosis based on clinical signs, microscopy and molecular findings, blood samples were collected from apparently healthy lactating cows (n = 184), pregnant heifers (n = 39) and newborn calves (n = 24). DNA was extracted from each sample and analyzed for the presence of major surface proteins (MSPs) of A. marginale, followed by sequencing to assess diversity of isolates. Microscopic examination of erythrocytes revealed A. marginale inclusion bodies in symptomatic cows. Examination of thin blood smears showed 3.8% of the lactating, clinically asymptomatic, cows to be infected with A. marginale, while nPCR detected 31.0% positive. A. marginale infection was not detected in pregnant heifers by either method. Congenital infection was found in one calf by nPCR. This is the first report of transplacental transmission of A. marginale in Turkey. The MSP4 sequence analyses showed high genetic diversity among the isolates, presenting 97.6-99.6% homology at the amino acid level. The sequences of MSP1a amplicons revealed genetic diversity providing three new tandem repeats.     

Follicular dysplasia in two cows

The histological features of a follicular dysplasia with pigmentary changes is reported in two adult cows, one a black Brangus-cross and the other a black Angus. Adult onset of diffuse alopecia was present in both cows. Skin biopsies exhibited follicular distortion and atrophy, with melanin clumping in follicular epithelium, hair bulb matrix cells, hair shafts, and infundibular keratin. Both animals were clinically normal apart from the alopecia. This report confirms and expands on the infrequently reported syndrome of follicular dysplasia in cattle.     

Atrial fibrillation associated with neostigmine administration in three cows

Three cattle with gastrointestinal disease were given neostigmine as part of the treatment for postsurgical ileus. All 3 cattle developed atrial fibrillation either before or during neostigmine administration, and 2 converted to normal sinus rhythm after cessation of treatment.     

Corticosteroid-responsive thrombocytopenia in two beef cows

Corticosteroid-responsive thrombocytopenia was identified in 2 beef cows. Clinical findings in 1 cow included hematoma formation, petechiation of mucous membranes, anemia, and persistent thrombocytopenia. Cow 2 was in its fourth month of gestation and had epistaxis, nasal mucosal petechiation, anemia, and thrombocytopenia. Treatment included parenteral administration of corticosteroids at immunosuppressive dosages. Cow 1 had a history of chronic hematoma formation and responded to long-term treatment with dexamethasone, but it relapsed 2 months after treatment was discontinued. Cow 2 had acute onset of clinical signs, responded to short-term treatment with prednisone, delivered a full-term, healthy calf, and remained clinically normal for at least 1 year after treatment was completed. Reported causes of thrombocytopenia in ruminants were ruled out or seemed unlikely; a definitive cause for thrombocytopenia in the 2 cows could not be established.